Fig. 4
From: Pharmacological effects of bile acids on polycystic ovary syndrome via the regulation of chemerin

Effects of bile acid treatments on ovarian histopathological parameters in PCOS. This figure presents the impact of various bile acid treatments on different ovarian histopathological parameters in a PCOS model. The eight subfigures (A–H) depict measurements across different groups, including control, PCOS, and multiple treatment groups with low and high doses of different bile acids. A Number of cystic follicles: Shows the count of cystic follicles across groups; B Number of atretic follicles: Illustrates the count of atretic follicles; C Number of antral follicles: Displays the count of antral follicles; D Number of corpus luteum: Shows the count of corpus luteum across groups; E Cystic follicle percentage: Displays the percentage of cystic follicles in all parameters; F Atretic follicle percentage: Illustrates the percentage of atretic follicles in all parameters; G Antral follicle percentage: Displays the percentage of antral follicles in all parameters; H Corpus luteum percentage: Shows the percentage of corpus luteum in all parameters. All data are presented as the mean ± standard deviation (SD), and statistical significance is denoted by asterisks (*) and hashes (#). Hashes (#): Indicate significant differences between the PCOS group and the control group (#, P < 0.05; ##, P < 0.01; ###, P < 0.001); Asterisks (*): Indicate significant differences between treatment groups and the PCOS group (*, P < 0.05; **, P < 0.01; ***, P < 0.001)